Streetbeat News

Products Services

GRTS

Gritstone bio has published interim results from its Phase 1 study of a self-amplifying mRNA vaccine against COVID-19 in Nature Communications. The results show promising safety and immunogenicity data.

Portfolio Pulse from Benzinga Newsdesk

June 08, 2023 | 11:09 am

AMZN

DIS

GOOG

GOOGL

META

NFLX

PARA

WBD

Amazon is considering launching an ad-supported Prime Video tier to expand its ad business and generate more entertainment revenue. The move could inspire other streaming platforms like Netflix and Disney to follow suit. Amazon is also in talks with Warner Bros. Discovery and Paramount Global to add ad-based tiers of their streaming services through Prime Video Channels.

Portfolio Pulse from Anusuya Lahiri

June 08, 2023 | 11:09 am

NSTG

Acrobat Genomics, Nanostring Technologies (NSTG), and the Illumina Accelerator have announced a collaboration with Stanford Medicine to discover new drug targets for gene editing-based therapeutics using GeoMx Digital Spatial Profiling Technology. The partnership aims to improve treatment options for patients suffering from interstitial lung diseases, such as idiopathic pulmonary fibrosis.

Portfolio Pulse from Benzinga Newsdesk

June 08, 2023 | 11:07 am

CING

Cingulate has completed its Phase 3 adult dose-optimization trial for CTX-1301, a treatment for Attention Deficit/Hyperactivity Disorder (ADHD). Results are expected in 3Q 2023, with pivotal Phase 3 trials in pediatric/adolescent patients scheduled for initiation in the same quarter.

Portfolio Pulse from Benzinga Newsdesk

June 08, 2023 | 11:04 am

LIAN

LianBio has completed enrollment in its pivotal Phase 3 LIBRA trial of TP-03 for Chinese patients with Demodex blepharitis. The trial aims to evaluate the safety and efficacy of TP-03 in treating the condition.

Portfolio Pulse from Benzinga Newsdesk

June 08, 2023 | 11:02 am

BCDA

BioCardia has been granted a patent in Japan for its Helix biotherapeutic delivery system, which is designed to improve the delivery of cell and gene therapies. The patent expands the company's intellectual property portfolio and may open up new market opportunities.

Portfolio Pulse from Benzinga Newsdesk

June 08, 2023 | 11:01 am

RCKT

Rocket Pharmaceuticals has received FDA Fast Track and Orphan Drug Designations for its RP-A601 gene therapy for PKP2 Arrhythmogenic Cardiomyopathy. This will expedite the development and review process for the therapy.

Portfolio Pulse from Benzinga Newsdesk

June 08, 2023 | 11:01 am

TSLA

Tesla is considering building a car factory in Spain, according to Cinco Dias. The electric vehicle manufacturer is reportedly in negotiations to establish a production facility in Valencia.

Portfolio Pulse from Charles Gross

June 08, 2023 | 10:53 am

MRK

The FDA has accepted Merck's sBLA for KEYTRUDA in combination with chemotherapy for the treatment of advanced or unresectable biliary tract cancer. The application is based on the KEYNOTE-966 trial, which showed a significant improvement in overall survival compared to chemotherapy alone.

Portfolio Pulse from Benzinga Newsdesk

June 08, 2023 | 10:47 am

FXI

LCID

Lucid Motors plans to sell imported cars in China and is considering local production, according to a person familiar with the matter.

Portfolio Pulse from Charles Gross

June 08, 2023 | 10:46 am